RZLT

4.53

2.16% -0.10

Handel nachbörslich: 4.48 -0.05 -1.10%

Rezolute Inc (RZLT)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$4.63

Offen:

$4.79

24-Stunden-Volumen:

357.98K

Relative Volume:

0.81

Marktkapitalisierung:

$274.23M

Einnahmen:

Nettoeinkommen (Verlust:

$-69.31M

KGV:

-3.5669

EPS:

-1.27

Netto-Cashflow:

$-62.80M

1W Leistung:

-1.74%

1M Leistung:

-7.93%

6M Leistung:

+4.14%

1J Leistung:

+208.16%

1-Tages-Spanne:

$4.48

$4.79

1-Wochen-Bereich:

$4.48

$4.80

52-Wochen-Spanne:

$1.49

$6.1856

Rezolute Inc Stock (RZLT) Company Profile

Firmenname

Rezolute Inc

Sektor

Healthcare (1169)

Branche

Biotechnology (678)

Telefon

650-206-4507

Adresse

275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-02-11

Neueste SEC-Einreichungen

RZLT's Discussions on Twitter

Vergleichen Sie RZLT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RZLT Rezolute Inc	4.53	274.23M	0	-69.31M	-62.80M	-1.27
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Rezolute Inc Stock (RZLT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-05	Eingeleitet	Wedbush	Outperform
2024-08-27	Eingeleitet	Guggenheim	Buy
2024-07-17	Eingeleitet	BTIG Research	Buy
2024-06-04	Eingeleitet	Craig Hallum	Buy
2024-04-09	Eingeleitet	Maxim Group	Buy
2022-08-02	Fortgesetzt	Canaccord Genuity	Buy
2022-06-15	Eingeleitet	Cantor Fitzgerald	Overweight
2021-09-08	Eingeleitet	ROTH Capital	Buy
2021-05-27	Eingeleitet	Oppenheimer	Outperform
2021-05-25	Eingeleitet	H.C. Wainwright	Buy

Alle ansehen

Rezolute Inc Aktie (RZLT) Neueste Nachrichten

03:25 AM

Insider Buying: Wladimir Hogenhuis Acquires Additional Shares of Rezolute Inc (RZLT) - GuruFocus.com

03:25 AM

Feb 21, 2025

Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares By Investing.com - Investing.com Nigeria

Feb 21, 2025

Feb 20, 2025

Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares - Investing.com India

Feb 20, 2025

Hedge Fund and Insider Trading News: Scott Bessent, Warren Buffett, Stanley Druckenmiller, Tybourne Capital Management, Millennium Management, Rezolute Inc (RZLT), Rambus Inc (RMBS), and More - Insider Monkey

Feb 20, 2025

JMP Securities Issues Positive Forecast for Rezolute (NASDAQ:RZLT) Stock Price - MarketBeat

Feb 18, 2025

Rezolute: Late-Stage Study Targeting Hyperinsulinism (NASDAQ:RZLT) - Seeking Alpha

Feb 18, 2025

Feb 17, 2025

Rezolute's SWOT analysis: biotech stock advances on ersodetug trials - MSN

Feb 17, 2025

What is Wedbush’s Estimate for Rezolute FY2029 Earnings? - Defense World

Feb 17, 2025

What is Wedbush's Estimate for Rezolute FY2029 Earnings? - MarketBeat

Feb 17, 2025

What is HC Wainwright’s Estimate for Rezolute Q1 Earnings? - Defense World

Feb 17, 2025

Feb 16, 2025

Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat

Feb 16, 2025

Rezolute’s Strategic Advances in Rare Disease Therapies - MSN

Feb 16, 2025

Feb 14, 2025

Guggenheim Reiterates Buy Rating for Rezolute (NASDAQ:RZLT) - MarketBeat

Feb 14, 2025

Feb 13, 2025

JMP Securities lifts Rezolute stock target to $9, maintains rating By Investing.com - Investing.com Australia

Feb 13, 2025

JMP Securities lifts Rezolute stock target to $9, maintains rating - MSN

Feb 13, 2025

Feb 12, 2025

Rezolute Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 12, 2025